Study questions worth of ultrasound and removing benign ovarian cysts in preventing cancer
This article was originally published in Clinica
Executive Summary
A 15-year study of over 5,000 women in the UK has shown for the first time that removing benign ovarian cysts does not reduce a woman's chance of dying from ovarian cancer. The study has also questioned the value of ultrasound as a cost-effective screening tool for the disease.
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.